Global Anti Infective Vaccines Market Research Report 2025(Status and Outlook)

September 2025 | 158 pages | ID: GC2674E3E374EN
Bosson Research

Abstracts

Anti-infective vaccines represent a class of biologics designed to stimulate the immune system to produce antibodies against specific pathogens, including bacteria, viruses, and other microorganisms, thereby preventing or mitigating infectious diseases; these vaccines can be categorized by their formulation?such as live attenuated, inactivated, subunit, or mRNA-based?and are administered through various routes, including intramuscular, oral, or intranasal, to induce both humoral and cellular immunity while minimizing the risk of disease transmission. The global market for anti-infective vaccines is characterized by robust growth driven by increasing prevalence of infectious diseases, rising public health initiatives, technological advancements in vaccine development, and growing government and private investments in immunization programs; key segments include pediatric vaccines, adult and travel vaccines, and emerging categories such as therapeutic vaccines for chronic infections, with dominant players including multinational pharmaceutical companies and biotech firms focusing on innovation in adjuvants, delivery systems, and broad-spectrum protection. Regional dynamics show high demand in North America and Europe due to well-established healthcare infrastructure and high awareness, while Asia-Pacific exhibits the fastest growth rate fueled by expanding population, improving access to healthcare, and rising incidences of infectious outbreaks; however, the market faces challenges such as stringent regulatory requirements, high R&D costs, vaccine hesitancy, and logistical issues in cold-chain management, though opportunities abound in the development of combination vaccines, personalized immunization approaches, and expansion into underserved markets.

The global Anti Infective Vaccines market size was estimated at USD 59840.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.45% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Anti Infective Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Anti Infective Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Anti Infective Vaccines market.

Global Anti Infective Vaccines Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr LabsInc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth PharmaceuticalsInc.
Berna Biotech

Market Segmentation (by Type)

Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines

Market Segmentation (by Application)

Bacterial Diseases
Viral Diseases

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti Infective Vaccines Market
Overview of the regional outlook of the Anti Infective Vaccines Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti Infective Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Anti Infective Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Anti Infective Vaccines
1.2 Key Market Segments
  1.2.1 Anti Infective Vaccines Segment by Type
  1.2.2 Anti Infective Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ANTI INFECTIVE VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Anti Infective Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Anti Infective Vaccines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ANTI INFECTIVE VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Anti Infective Vaccines Product Life Cycle
3.3 Global Anti Infective Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Anti Infective Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Anti Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Anti Infective Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Anti Infective Vaccines Market Competitive Situation and Trends
  3.8.1 Anti Infective Vaccines Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Anti Infective Vaccines Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ANTI INFECTIVE VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Anti Infective Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ANTI INFECTIVE VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Anti Infective Vaccines Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Anti Infective Vaccines Market
5.7 ESG Ratings of Leading Companies

6 ANTI INFECTIVE VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti Infective Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Anti Infective Vaccines Market Size Market Share by Type (2020-2025)
6.4 Global Anti Infective Vaccines Price by Type (2020-2025)

7 ANTI INFECTIVE VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti Infective Vaccines Market Sales by Application (2020-2025)
7.3 Global Anti Infective Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Anti Infective Vaccines Sales Growth Rate by Application (2020-2025)

8 ANTI INFECTIVE VACCINES MARKET SALES BY REGION

8.1 Global Anti Infective Vaccines Sales by Region
  8.1.1 Global Anti Infective Vaccines Sales by Region
  8.1.2 Global Anti Infective Vaccines Sales Market Share by Region
8.2 Global Anti Infective Vaccines Market Size by Region
  8.2.1 Global Anti Infective Vaccines Market Size by Region
  8.2.2 Global Anti Infective Vaccines Market Size Market Share by Region
8.3 North America
  8.3.1 North America Anti Infective Vaccines Sales by Country
  8.3.2 North America Anti Infective Vaccines Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Anti Infective Vaccines Sales by Country
  8.4.2 Europe Anti Infective Vaccines Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Anti Infective Vaccines Sales by Region
  8.5.2 Asia Pacific Anti Infective Vaccines Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Anti Infective Vaccines Sales by Country
  8.6.2 South America Anti Infective Vaccines Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Anti Infective Vaccines Sales by Region
  8.7.2 Middle East and Africa Anti Infective Vaccines Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ANTI INFECTIVE VACCINES MARKET PRODUCTION BY REGION

9.1 Global Production of Anti Infective Vaccines by Region(2020-2025)
9.2 Global Anti Infective Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Anti Infective Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Anti Infective Vaccines Production
  9.4.1 North America Anti Infective Vaccines Production Growth Rate (2020-2025)
  9.4.2 North America Anti Infective Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Anti Infective Vaccines Production
  9.5.1 Europe Anti Infective Vaccines Production Growth Rate (2020-2025)
  9.5.2 Europe Anti Infective Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Anti Infective Vaccines Production (2020-2025)
  9.6.1 Japan Anti Infective Vaccines Production Growth Rate (2020-2025)
  9.6.2 Japan Anti Infective Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Anti Infective Vaccines Production (2020-2025)
  9.7.1 China Anti Infective Vaccines Production Growth Rate (2020-2025)
  9.7.2 China Anti Infective Vaccines Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Emergent BioDefense Operations Lansing Inc.
  10.1.1 Emergent BioDefense Operations Lansing Inc. Basic Information
  10.1.2 Emergent BioDefense Operations Lansing Inc. Anti Infective Vaccines Product Overview
  10.1.3 Emergent BioDefense Operations Lansing Inc. Anti Infective Vaccines Product Market Performance
  10.1.4 Emergent BioDefense Operations Lansing Inc. Business Overview
  10.1.5 Emergent BioDefense Operations Lansing Inc. SWOT Analysis
  10.1.6 Emergent BioDefense Operations Lansing Inc. Recent Developments
10.2 Sanofi Pasteur
  10.2.1 Sanofi Pasteur Basic Information
  10.2.2 Sanofi Pasteur Anti Infective Vaccines Product Overview
  10.2.3 Sanofi Pasteur Anti Infective Vaccines Product Market Performance
  10.2.4 Sanofi Pasteur Business Overview
  10.2.5 Sanofi Pasteur SWOT Analysis
  10.2.6 Sanofi Pasteur Recent Developments
10.3 Merck and Co.
  10.3.1 Merck and Co. Basic Information
  10.3.2 Merck and Co. Anti Infective Vaccines Product Overview
  10.3.3 Merck and Co. Anti Infective Vaccines Product Market Performance
  10.3.4 Merck and Co. Business Overview
  10.3.5 Merck and Co. SWOT Analysis
  10.3.6 Merck and Co. Recent Developments
10.4 MedImmune LLC
  10.4.1 MedImmune LLC Basic Information
  10.4.2 MedImmune LLC Anti Infective Vaccines Product Overview
  10.4.3 MedImmune LLC Anti Infective Vaccines Product Market Performance
  10.4.4 MedImmune LLC Business Overview
  10.4.5 MedImmune LLC Recent Developments
10.5 Novartis Vaccines
  10.5.1 Novartis Vaccines Basic Information
  10.5.2 Novartis Vaccines Anti Infective Vaccines Product Overview
  10.5.3 Novartis Vaccines Anti Infective Vaccines Product Market Performance
  10.5.4 Novartis Vaccines Business Overview
  10.5.5 Novartis Vaccines Recent Developments
10.6 Diagnostics Ltd.
  10.6.1 Diagnostics Ltd. Basic Information
  10.6.2 Diagnostics Ltd. Anti Infective Vaccines Product Overview
  10.6.3 Diagnostics Ltd. Anti Infective Vaccines Product Market Performance
  10.6.4 Diagnostics Ltd. Business Overview
  10.6.5 Diagnostics Ltd. Recent Developments
10.7 Intercell Biomedical
  10.7.1 Intercell Biomedical Basic Information
  10.7.2 Intercell Biomedical Anti Infective Vaccines Product Overview
  10.7.3 Intercell Biomedical Anti Infective Vaccines Product Market Performance
  10.7.4 Intercell Biomedical Business Overview
  10.7.5 Intercell Biomedical Recent Developments
10.8 MassBiologics
  10.8.1 MassBiologics Basic Information
  10.8.2 MassBiologics Anti Infective Vaccines Product Overview
  10.8.3 MassBiologics Anti Infective Vaccines Product Market Performance
  10.8.4 MassBiologics Business Overview
  10.8.5 MassBiologics Recent Developments
10.9 Barr LabsInc.
  10.9.1 Barr LabsInc. Basic Information
  10.9.2 Barr LabsInc. Anti Infective Vaccines Product Overview
  10.9.3 Barr LabsInc. Anti Infective Vaccines Product Market Performance
  10.9.4 Barr LabsInc. Business Overview
  10.9.5 Barr LabsInc. Recent Developments
10.10 Organon Teknika Co.
  10.10.1 Organon Teknika Co. Basic Information
  10.10.2 Organon Teknika Co. Anti Infective Vaccines Product Overview
  10.10.3 Organon Teknika Co. Anti Infective Vaccines Product Market Performance
  10.10.4 Organon Teknika Co. Business Overview
  10.10.5 Organon Teknika Co. Recent Developments
10.11 GlaxoSmithKline Biologicals
  10.11.1 GlaxoSmithKline Biologicals Basic Information
  10.11.2 GlaxoSmithKline Biologicals Anti Infective Vaccines Product Overview
  10.11.3 GlaxoSmithKline Biologicals Anti Infective Vaccines Product Market Performance
  10.11.4 GlaxoSmithKline Biologicals Business Overview
  10.11.5 GlaxoSmithKline Biologicals Recent Developments
10.12 CSL Ltd.
  10.12.1 CSL Ltd. Basic Information
  10.12.2 CSL Ltd. Anti Infective Vaccines Product Overview
  10.12.3 CSL Ltd. Anti Infective Vaccines Product Market Performance
  10.12.4 CSL Ltd. Business Overview
  10.12.5 CSL Ltd. Recent Developments
10.13 ID Biomedical Co.
  10.13.1 ID Biomedical Co. Basic Information
  10.13.2 ID Biomedical Co. Anti Infective Vaccines Product Overview
  10.13.3 ID Biomedical Co. Anti Infective Vaccines Product Market Performance
  10.13.4 ID Biomedical Co. Business Overview
  10.13.5 ID Biomedical Co. Recent Developments
10.14 Protein Sciences Co.
  10.14.1 Protein Sciences Co. Basic Information
  10.14.2 Protein Sciences Co. Anti Infective Vaccines Product Overview
  10.14.3 Protein Sciences Co. Anti Infective Vaccines Product Market Performance
  10.14.4 Protein Sciences Co. Business Overview
  10.14.5 Protein Sciences Co. Recent Developments
10.15 Wyeth PharmaceuticalsInc.
  10.15.1 Wyeth PharmaceuticalsInc. Basic Information
  10.15.2 Wyeth PharmaceuticalsInc. Anti Infective Vaccines Product Overview
  10.15.3 Wyeth PharmaceuticalsInc. Anti Infective Vaccines Product Market Performance
  10.15.4 Wyeth PharmaceuticalsInc. Business Overview
  10.15.5 Wyeth PharmaceuticalsInc. Recent Developments
10.16 Berna Biotech
  10.16.1 Berna Biotech Basic Information
  10.16.2 Berna Biotech Anti Infective Vaccines Product Overview
  10.16.3 Berna Biotech Anti Infective Vaccines Product Market Performance
  10.16.4 Berna Biotech Business Overview
  10.16.5 Berna Biotech Recent Developments

11 ANTI INFECTIVE VACCINES MARKET FORECAST BY REGION

11.1 Global Anti Infective Vaccines Market Size Forecast
11.2 Global Anti Infective Vaccines Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Anti Infective Vaccines Market Size Forecast by Country
  11.2.3 Asia Pacific Anti Infective Vaccines Market Size Forecast by Region
  11.2.4 South America Anti Infective Vaccines Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Anti Infective Vaccines by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Anti Infective Vaccines Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Anti Infective Vaccines by Type (2026-2033)
  12.1.2 Global Anti Infective Vaccines Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Anti Infective Vaccines by Type (2026-2033)
12.2 Global Anti Infective Vaccines Market Forecast by Application (2026-2033)
  12.2.1 Global Anti Infective Vaccines Sales (K MT) Forecast by Application
  12.2.2 Global Anti Infective Vaccines Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti Infective Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Anti Infective Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Anti Infective Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Anti Infective Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Anti Infective Vaccines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Infective Vaccines as of 2024)
Table 10. Global Market Anti Infective Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Anti Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Anti Infective Vaccines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Anti Infective Vaccines Sales by Type (K MT)
Table 26. Global Anti Infective Vaccines Market Size by Type (M USD)
Table 27. Global Anti Infective Vaccines Sales (K MT) by Type (2020-2025)
Table 28. Global Anti Infective Vaccines Sales Market Share by Type (2020-2025)
Table 29. Global Anti Infective Vaccines Market Size (M USD) by Type (2020-2025)
Table 30. Global Anti Infective Vaccines Market Size Share by Type (2020-2025)
Table 31. Global Anti Infective Vaccines Price (USD/KG) by Type (2020-2025)
Table 32. Global Anti Infective Vaccines Sales (K MT) by Application
Table 33. Global Anti Infective Vaccines Market Size by Application
Table 34. Global Anti Infective Vaccines Sales by Application (2020-2025) & (K MT)
Table 35. Global Anti Infective Vaccines Sales Market Share by Application (2020-2025)
Table 36. Global Anti Infective Vaccines Market Size by Application (2020-2025) & (M USD)
Table 37. Global Anti Infective Vaccines Market Share by Application (2020-2025)
Table 38. Global Anti Infective Vaccines Sales Growth Rate by Application (2020-2025)
Table 39. Global Anti Infective Vaccines Sales by Region (2020-2025) & (K MT)
Table 40. Global Anti Infective Vaccines Sales Market Share by Region (2020-2025)
Table 41. Global Anti Infective Vaccines Market Size by Region (2020-2025) & (M USD)
Table 42. Global Anti Infective Vaccines Market Size Market Share by Region (2020-2025)
Table 43. North America Anti Infective Vaccines Sales by Country (2020-2025) & (K MT)
Table 44. North America Anti Infective Vaccines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Anti Infective Vaccines Sales by Country (2020-2025) & (K MT)
Table 46. Europe Anti Infective Vaccines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Anti Infective Vaccines Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Anti Infective Vaccines Market Size by Region (2020-2025) & (M USD)
Table 49. South America Anti Infective Vaccines Sales by Country (2020-2025) & (K MT)
Table 50. South America Anti Infective Vaccines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Anti Infective Vaccines Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Anti Infective Vaccines Market Size by Region (2020-2025) & (M USD)
Table 53. Global Anti Infective Vaccines Production (K MT) by Region(2020-2025)
Table 54. Global Anti Infective Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Anti Infective Vaccines Revenue Market Share by Region (2020-2025)
Table 56. Global Anti Infective Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Anti Infective Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Anti Infective Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Anti Infective Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Anti Infective Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Emergent BioDefense Operations Lansing Inc. Basic Information
Table 62. Emergent BioDefense Operations Lansing Inc. Anti Infective Vaccines Product Overview
Table 63. Emergent BioDefense Operations Lansing Inc. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Emergent BioDefense Operations Lansing Inc. Business Overview
Table 65. Emergent BioDefense Operations Lansing Inc. SWOT Analysis
Table 66. Emergent BioDefense Operations Lansing Inc. Recent Developments
Table 67. Sanofi Pasteur Basic Information
Table 68. Sanofi Pasteur Anti Infective Vaccines Product Overview
Table 69. Sanofi Pasteur Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Sanofi Pasteur Business Overview
Table 71. Sanofi Pasteur SWOT Analysis
Table 72. Sanofi Pasteur Recent Developments
Table 73. Merck and Co. Basic Information
Table 74. Merck and Co. Anti Infective Vaccines Product Overview
Table 75. Merck and Co. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Merck and Co. Business Overview
Table 77. Merck and Co. SWOT Analysis
Table 78. Merck and Co. Recent Developments
Table 79. MedImmune LLC Basic Information
Table 80. MedImmune LLC Anti Infective Vaccines Product Overview
Table 81. MedImmune LLC Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. MedImmune LLC Business Overview
Table 83. MedImmune LLC Recent Developments
Table 84. Novartis Vaccines Basic Information
Table 85. Novartis Vaccines Anti Infective Vaccines Product Overview
Table 86. Novartis Vaccines Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Novartis Vaccines Business Overview
Table 88. Novartis Vaccines Recent Developments
Table 89. Diagnostics Ltd. Basic Information
Table 90. Diagnostics Ltd. Anti Infective Vaccines Product Overview
Table 91. Diagnostics Ltd. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Diagnostics Ltd. Business Overview
Table 93. Diagnostics Ltd. Recent Developments
Table 94. Intercell Biomedical Basic Information
Table 95. Intercell Biomedical Anti Infective Vaccines Product Overview
Table 96. Intercell Biomedical Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Intercell Biomedical Business Overview
Table 98. Intercell Biomedical Recent Developments
Table 99. MassBiologics Basic Information
Table 100. MassBiologics Anti Infective Vaccines Product Overview
Table 101. MassBiologics Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. MassBiologics Business Overview
Table 103. MassBiologics Recent Developments
Table 104. Barr LabsInc. Basic Information
Table 105. Barr LabsInc. Anti Infective Vaccines Product Overview
Table 106. Barr LabsInc. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Barr LabsInc. Business Overview
Table 108. Barr LabsInc. Recent Developments
Table 109. Organon Teknika Co. Basic Information
Table 110. Organon Teknika Co. Anti Infective Vaccines Product Overview
Table 111. Organon Teknika Co. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Organon Teknika Co. Business Overview
Table 113. Organon Teknika Co. Recent Developments
Table 114. GlaxoSmithKline Biologicals Basic Information
Table 115. GlaxoSmithKline Biologicals Anti Infective Vaccines Product Overview
Table 116. GlaxoSmithKline Biologicals Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. GlaxoSmithKline Biologicals Business Overview
Table 118. GlaxoSmithKline Biologicals Recent Developments
Table 119. CSL Ltd. Basic Information
Table 120. CSL Ltd. Anti Infective Vaccines Product Overview
Table 121. CSL Ltd. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. CSL Ltd. Business Overview
Table 123. CSL Ltd. Recent Developments
Table 124. ID Biomedical Co. Basic Information
Table 125. ID Biomedical Co. Anti Infective Vaccines Product Overview
Table 126. ID Biomedical Co. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. ID Biomedical Co. Business Overview
Table 128. ID Biomedical Co. Recent Developments
Table 129. Protein Sciences Co. Basic Information
Table 130. Protein Sciences Co. Anti Infective Vaccines Product Overview
Table 131. Protein Sciences Co. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Protein Sciences Co. Business Overview
Table 133. Protein Sciences Co. Recent Developments
Table 134. Wyeth PharmaceuticalsInc. Basic Information
Table 135. Wyeth PharmaceuticalsInc. Anti Infective Vaccines Product Overview
Table 136. Wyeth PharmaceuticalsInc. Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Wyeth PharmaceuticalsInc. Business Overview
Table 138. Wyeth PharmaceuticalsInc. Recent Developments
Table 139. Berna Biotech Basic Information
Table 140. Berna Biotech Anti Infective Vaccines Product Overview
Table 141. Berna Biotech Anti Infective Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Berna Biotech Business Overview
Table 143. Berna Biotech Recent Developments
Table 144. Global Anti Infective Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 145. Global Anti Infective Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Anti Infective Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 147. North America Anti Infective Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Anti Infective Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 149. Europe Anti Infective Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Anti Infective Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 151. Asia Pacific Anti Infective Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Anti Infective Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 153. South America Anti Infective Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Anti Infective Vaccines Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Anti Infective Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Anti Infective Vaccines Sales Forecast by Type (2026-2033) & (K MT)
Table 157. Global Anti Infective Vaccines Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Anti Infective Vaccines Price Forecast by Type (2026-2033) & (USD/KG)
Table 159. Global Anti Infective Vaccines Sales (K MT) Forecast by Application (2026-2033)
Table 160. Global Anti Infective Vaccines Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Anti Infective Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti Infective Vaccines Market Size (M USD), 2024-2033
Figure 5. Global Anti Infective Vaccines Market Size (M USD) (2020-2033)
Figure 6. Global Anti Infective Vaccines Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti Infective Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Anti Infective Vaccines Product Life Cycle
Figure 13. Anti Infective Vaccines Sales Share by Manufacturers in 2024
Figure 14. Global Anti Infective Vaccines Revenue Share by Manufacturers in 2024
Figure 15. Anti Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Anti Infective Vaccines Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Anti Infective Vaccines Revenue in 2024
Figure 18. Industry Chain Map of Anti Infective Vaccines
Figure 19. Global Anti Infective Vaccines Market PEST Analysis
Figure 20. Global Anti Infective Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Anti Infective Vaccines Market Share by Type
Figure 27. Sales Market Share of Anti Infective Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Anti Infective Vaccines by Type in 2024
Figure 29. Market Size Share of Anti Infective Vaccines by Type (2020-2025)
Figure 30. Market Size Share of Anti Infective Vaccines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Anti Infective Vaccines Market Share by Application
Figure 33. Global Anti Infective Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Anti Infective Vaccines Sales Market Share by Application in 2024
Figure 35. Global Anti Infective Vaccines Market Share by Application (2020-2025)
Figure 36. Global Anti Infective Vaccines Market Share by Application in 2024
Figure 37. Global Anti Infective Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Anti Infective Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Anti Infective Vaccines Market Size Market Share by Region (2020-2025)
Figure 40. North America Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Anti Infective Vaccines Sales Market Share by Country in 2024
Figure 43. North America Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Anti Infective Vaccines Market Size Market Share by Country in 2024
Figure 45. U.S. Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Anti Infective Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Anti Infective Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Anti Infective Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Anti Infective Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Anti Infective Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Anti Infective Vaccines Market Size Market Share by Country in 2024
Figure 55. Germany Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Anti Infective Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Anti Infective Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Anti Infective Vaccines Market Size Market Share by Region in 2024
Figure 68. China Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Anti Infective Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Anti Infective Vaccines Sales Market Share by Country in 2024
Figure 80. South America Anti Infective Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Anti Infective Vaccines Market Size Market Share by Country in 2024
Figure 82. Brazil Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Anti Infective Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Anti Infective Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Anti Infective Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Anti Infective Vaccines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Anti Infective Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Anti Infective Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Anti Infective Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Anti Infective Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Anti Infective Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Anti Infective Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Anti Infective Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Anti Infective Vaccines Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Anti Infective Vaccines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Anti Infective Vaccines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Anti Infective Vaccines Market Share Forecast by Type (2026-2033)
Figure 111. Global Anti Infective Vaccines Sales Forecast by Application (2026-2033)
Figure 112. Global Anti Infective Vaccines Market Share Forecast by Application (2026-2033)